Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference
Steffen Naegel, Mark ObermannDepartment of Neurology, University of Duisburg-Essen, Hufelandstr. 55, 45122 Essen, GermanyAbstract: Migraine is a very common disorder characterized by the combination of typical headache with associated autonomic symptoms and/or the presence of aura. Considerable adva...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2009-12-01
|
| Series: | Neuropsychiatric Disease and Treatment |
| Online Access: | http://www.dovepress.com/topiramate-in-the-prevention-and-treatment-of-migraine-efficacy-safety-a3874 |
| _version_ | 1828958832374579200 |
|---|---|
| author | Steffen Naegel Mark Obermann |
| author_facet | Steffen Naegel Mark Obermann |
| author_sort | Steffen Naegel |
| collection | DOAJ |
| description | Steffen Naegel, Mark ObermannDepartment of Neurology, University of Duisburg-Essen, Hufelandstr. 55, 45122 Essen, GermanyAbstract: Migraine is a very common disorder characterized by the combination of typical headache with associated autonomic symptoms and/or the presence of aura. Considerable advances have been made in recent years to understand the pathophysiology of migraine, which has led to improved treatment options for the acute migraine attack as well as migraine prophylaxis. Unfortunately, preventive treatment is often insufficient to decrease migraine frequency substantially or is not well tolerated. Topiramate is an antipileptic drug with a complex mode of action which has proven its efficacy and safety in the prophylactic treatment of episodic migraine in a number of randomized controlled clinical trials. Topiramate is also effective in treating patients with chronic migraine. It has little pharmacological interaction with other drugs and is generally well tolerated by patients.Keywords: migraine, antiepileptic drugs, topiramate |
| first_indexed | 2024-12-14T08:56:00Z |
| format | Article |
| id | doaj.art-d98a33ce43c74944b5851239c03d8138 |
| institution | Directory Open Access Journal |
| issn | 1176-6328 1178-2021 |
| language | English |
| last_indexed | 2024-12-14T08:56:00Z |
| publishDate | 2009-12-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Neuropsychiatric Disease and Treatment |
| spelling | doaj.art-d98a33ce43c74944b5851239c03d81382022-12-21T23:08:56ZengDove Medical PressNeuropsychiatric Disease and Treatment1176-63281178-20212009-12-012010Issue 11728Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preferenceSteffen NaegelMark ObermannSteffen Naegel, Mark ObermannDepartment of Neurology, University of Duisburg-Essen, Hufelandstr. 55, 45122 Essen, GermanyAbstract: Migraine is a very common disorder characterized by the combination of typical headache with associated autonomic symptoms and/or the presence of aura. Considerable advances have been made in recent years to understand the pathophysiology of migraine, which has led to improved treatment options for the acute migraine attack as well as migraine prophylaxis. Unfortunately, preventive treatment is often insufficient to decrease migraine frequency substantially or is not well tolerated. Topiramate is an antipileptic drug with a complex mode of action which has proven its efficacy and safety in the prophylactic treatment of episodic migraine in a number of randomized controlled clinical trials. Topiramate is also effective in treating patients with chronic migraine. It has little pharmacological interaction with other drugs and is generally well tolerated by patients.Keywords: migraine, antiepileptic drugs, topiramatehttp://www.dovepress.com/topiramate-in-the-prevention-and-treatment-of-migraine-efficacy-safety-a3874 |
| spellingShingle | Steffen Naegel Mark Obermann Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference Neuropsychiatric Disease and Treatment |
| title | Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference |
| title_full | Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference |
| title_fullStr | Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference |
| title_full_unstemmed | Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference |
| title_short | Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference |
| title_sort | topiramate in the prevention and treatment of migraine efficacy safety and patient preference |
| url | http://www.dovepress.com/topiramate-in-the-prevention-and-treatment-of-migraine-efficacy-safety-a3874 |
| work_keys_str_mv | AT steffennaegel topiramateinthepreventionandtreatmentofmigraineefficacysafetyandpatientpreference AT markobermann topiramateinthepreventionandtreatmentofmigraineefficacysafetyandpatientpreference |